Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2020/21 parent results

May 14 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             4.20            6.01                                 
                 (-30.1 pct)     (-61.5 pct)                             
  Operating         2.49            4.13                                 
                 (-39.8 pct)     (-69.8 pct)                             
  Recurring         2.47            4.08                                 
                 (-39.5 pct)     (-70.1 pct)                             
  Net               1.87            3.10                                 
                 (-39.7 pct)     (-89.8 pct)                             
  EPS             23.40 yen       38.81 yen                              
  EPS Diluted     23.37 yen       38.77 yen                              
  Ann Div        100.00 yen      110.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         50.00 yen       60.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news